Home › Funds › WealthBridge Investment Counsel Inc. › ABT

WealthBridge Investment Counsel Inc. position in ABT

ABBOTT LABORATORIES · Health Care

WealthBridge Investment Counsel Inc. reported holding 63,680 shares of ABT (ABBOTT LABORATORIES) in its Q3 2026 13F filing — a position valued at US$6.3M, representing 1.67% of its reported portfolio and ranking #27 among its reported holdings. WealthBridge Investment Counsel Inc. has disclosed ABT holdings in 13 of the last 13 reported quarters, going back to Q3 2023.

Latest position (Q3 2026)63.68K sh
Reported value held$6.29M
Portfolio Weight1.67%
First reportedQ3 2023
Last changeHold
Updated2026-10-15

Last updated: 2026-10-15 · Source: SEC EDGAR Form 13F-HR

How WealthBridge Investment Counsel Inc.'s ABT position evolved

WealthBridge Investment Counsel Inc. first disclosed a stake in ABT in Q3 2023 at 62,380 shares (US$6.0M). The position peaked in Q2 2025 at 65,793 shares, worth US$8.9M. Across 13 filings, WealthBridge Investment Counsel Inc. increased the stake 3 time(s), trimmed it 1 time(s) and left it unchanged 8 time(s). The most recent filing (Q3 2026) shows 63,680 shares valued at US$6.3M.

Quarter by quarter

QuarterSharesValueChange
Q3 2023 62.38K $6.04M New
Q4 2023 63.35K $6.97M Add
Q1 2024 63.30K $7.20M Hold
Q2 2024 64.87K $6.74M Add
Q3 2024 64.99K $7.41M Hold
Q4 2024 64.74K $7.32M Hold
Q1 2025 64.64K $8.57M Hold
Q2 2025 65.79K $8.95M Add
Q3 2025 65.93K $8.83M Hold
Q4 2025 66.20K $8.29M Hold
Q1 2026 66.45K $6.82M Hold
Q2 2026 63.66K $5.78M Reduce
Q3 2026 63.68K $6.29M Hold

Dots on the line are colored by change type; missing quarters mean no position was reported.

About ABT and 13F data

ABT (ABBOTT LABORATORIES) is a Health Care company. 20 other funds we track also report a position in ABT — the largest reported positions include Vanguard Group (US$22.00B), Charles Schwab Investment Management (US$5.41B), CHARLES SCHWAB INVESTMENT MANAGEMENT INC (US$5.41B). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding ABT

All ABT fund holders →

FAQ

How long has WealthBridge Investment Counsel Inc. held ABT?

WealthBridge Investment Counsel Inc. has disclosed ABT holdings in 13 of the last 13 reported quarters, going back to Q3 2023.

What is WealthBridge Investment Counsel Inc.'s current position in ABT?

As of Q3 2026, WealthBridge Investment Counsel Inc. holds 63.68K shares of ABT (ABBOTT LABORATORIES), valued at $6.29M, representing 1.67% of its reported portfolio and ranking #27.

Has WealthBridge Investment Counsel Inc. been buying or selling ABT?

In the latest 13F filing (Q3 2026), WealthBridge Investment Counsel Inc. held unchanged its position in ABT. The position peaked in Q2 2025 at 65.79K shares.

Which other funds hold ABT?

Other major institutional holders of ABT include Vanguard Group, Charles Schwab Investment Management, CHARLES SCHWAB INVESTMENT MANAGEMENT INC, among 20 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.